Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2012 Sep 12;11(11):2526–2534. doi: 10.1158/1535-7163.MCT-12-0460

Figure 4.

Figure 4

(A) Progression-free survival (PFS) and (B) overall survival (OS) Kaplan Meier curves for all 17 patients according to EpCAM transcript expression in the CD326+ cell fraction. EpCAM high expression in green (n = 8); EpCAM low expression in blue (n = 9); time was measured from the basal blood draw to the death for OS and to radiologic evidence of disease progression (PFS).